skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Salmeterol/fluticasone combination in the treatment of COPD

(2381) Views  (534) Full article downloads

Authors: K F Chung

Published Date May 2006 Volume 2006:1(3) Pages 235 - 242
DOI: http://dx.doi.org/10.2147/COPD.S

K F Chung

National Heart and Lung Institute, Imperial College and Royal Brompton Hospital, London, UK

Abstract: Clinical trials of a combination therapy of an inhaled corticosteroid, fluticasone propionate (FP), with a long-acting β2-agonist, salmeterol (Sal), have demonstrated a greater improvement in lung function and in quality of life measures after the combination compared with either component of alone. In a subanalysis of the data of the TRISTAN study, Sal/FP reduced exacerbation rates in COPD patients with a baseline FEV1<50% of predicted. A combination therapy of budesonide and formoterol improved quality of life and FEV1, and reduced exacerbations better than either component alone. In studies of FP or of Sal/FP in COPD, there was a reduction in all-cause mortality by 25% relative to placebo. Sal/FP has anti-inflammatory effects in COPD airways. FP inhibits markers of systemic inflammation, and it is not known whether Sal/FP has an advantage over FP alone. While long-acting β2-agonists such as Sal can be recommended for treatment of moderate COPD, addition of inhaled steroid therapy such as FP should be considered in more severe disease.

Keywords: fluticasone, salmeterol, COPD








Readers of this article also read:

Pulmonary stem cells and the induction of tissue regeneration in the treatment of emphysema
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
Long-term oxygen therapy: Are we prescribing appropriately?
The influence of the media on COPD patients’ knowledge regarding cardiopulmonary resuscitation
Knowledge and attitudes of family physicians coming to COPD continuing medical education
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives
Retinal nerve fiber layer thickness in recovered and persistent amblyopia
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
Primary care for diabetes mellitus: perspective from older patients
  • Journal Indexing

    See where all the Dove Press journals are indexed

  • Testimonials

    "You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio